Stephen Badylak, DVM, PhD, MD
Professor of Surgery, University of Pittsburgh
Deputy Director of the McGowan Institute for Regenerative Medicine
Director of the Center for Preclinical Testing
Authored over 340 peer reviewed publications and 40 book chapters
Holds more than 60 issued U.S. patents and 300 patents worldwide
Co-founder of ECM Therapeutics, Inc.
Dr. Badylak is Deputy Director of the McGowan Institute for Regenerative Medicine, Director of the Center for Preclinical Testing, and directs a laboratory focused upon the use of biologic scaffolds composed of extracellular matrix (ECM) to facilitate functional tissue and organ reconstruction. Dr. Badylak is the past President of the Tissue Engineering and Regenerative Medicine International Society (TERMIS), the author of more than 300 peer reviewed publications, and holds more than 50 issued U.S. patents and 300 patents worldwide. Dr. Badylak is the editor of the textbook “Host Response to Biomaterials” (Academic Press, 2015) The focus of Dr. Badylak's work has been the mechanisms by which extracellular matrix signals host tissues to promote and support functional tissue reconstruction. Dr. Badylak places high emphasis upon clinical translation of all activities in the laboratory and work conducted within the laboratory spans the full spectrum from basic science at the subcellular level to patient care at the bed side.
Dr. Badylak’s laboratory specializes in the use of biologic scaffolds composed of extracellular matrix (ECM) to facilitate functional tissue and organ reconstruction. http://www.mirm.pitt.edu/badylak/team.asp
“Dr. Badylak is one of Pitt’s most prolific innovators, and we look forward to the positive impact that these regenerative medicine technologies will have on people’s lives.” - Alex Ducruet, PhD, CLP, director for licensing and intellectual property in Pitt’s Innovation Institute.